Positive Impact (PI) has announced that it is now the exclusive UK distributor for in-practice dry eye test InflammaDry.
The testing kit, which can aid help the diagnosis of dry eye in four steps, was said to be the first and only, rapid in-practice test that detects MMP-9, a biomarker for inflammation that is consistently elevated in the tears of patients with dry-eye disease.
Commenting on the announcement, Nick Atkins, joint managing Director of PI said: ‘We are delighted to be able to make this unique diagnostic tool available to UK dry eye practitioners in both optometry and ophthalmology.
‘All other dry eye tests measure tear production and stability. InflammaDry recognises elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods. This is a reliable and relatively low cost disposable test that is simple to use and gives a definitive result in just 10 minutes.’